SK1 expression is also higher in ER negative (ER–) tumors compared with ER+ breast tumors and this correlates with a poorer prognosis (Ruckhäberle et al., 2008), suggesting that expression levels of SK1 are associated with disease progression. This evidence concerns the gene SPHK1 and breast neoplasm.